Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3053725 | European Journal of Paediatric Neurology | 2013 | 6 Pages |
Abstract
Molybdenum cofactor deficiency is a rare inborn error of metabolism. The major clinical symptoms are intractable neonatal seizures, progressive encephalopathy, facial dysmorphic features and feeding difficulties. Most of the patients are misdiagnosed as hypoxic ischemic encephalopathy. The majority of patients have mutations in the MOCS1 and MOCS2 genes. Although the therapeutic treatment strategies have not been improved, genetic analysis is essential to elucidate the disease. Here, we report a review of 12 patients with Molybdenum cofactor deficiency reported from Turkey.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Erhan Bayram, Yasemin Topcu, Pakize Karakaya, Uluc Yis, Handan Cakmakci, Kimiyoshi Ichida, Semra Hiz Kurul,